Qiang Xu

SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade

Mingxia Zhao, Wenjie Guo, Yuanyuan Wu et al. · Acta Pharmaceutica Sinica B · 2018 · 186 citations · Full text

Life Sciences, Immunology, Oncology +14

Synthesis, DNA‐Binding, Cleavage, and Cytotoxic Activity of New 1,7‐Dioxa‐4,10‐diazacyclododecane Artificial Receptors Containing Bisguanidinoethyl or Diaminoethyl Double Side Arms

Xin Sheng, Xiaomin Lu, Yueting Chen et al. · Chemistry - A European Journal · 2007 · 113 citations

Pharmacy, Medicinal Chemistry, Molecular Biology +15

A New Flavanone Isolated from Rhizoma Smilacis Glabrae and the Structural Requirements of its Derivatives for Preventing Immunological Hepatocyte Damage

Ting Chen, Jianxin Li, Jingsong Cao et al. · Planta Medica · 1999 · 93 citations

Pharmacy, Biochemistry, Pharmacology +16

Protease Activity of PprI Facilitates DNA Damage Response: Mn(2+)-Dependence and Substrate Sequence-Specificity of the Proteolytic Reaction

Yunguang Wang, Qiang Xu, Huiming Lu et al. · PLoS ONE · 2015 · 66 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-κB and MAPK signaling pathways

Qiang Xu, Guiping Chen, Xuqiang Liu et al. · Biochemical and Biophysical Research Communications · 2018 · 59 citations

Medicine, Cell Biology, Pharmacology +13